Published in BMJ on July 15, 2011
Pain in Patients With Dementia and Behavioural Disturbances | NCT01021696
Diagnoses indicating pain and analgesic drug prescription in patients with dementia: a comparison to age- and sex-matched controls. BMC Geriatr (2014) 1.51
Impact of a stepwise protocol for treating pain on pain intensity in nursing home patients with dementia: a cluster randomized trial. Eur J Pain (2014) 1.50
Management of neuropsychiatric symptoms of dementia in clinical settings: recommendations from a multidisciplinary expert panel. J Am Geriatr Soc (2014) 1.35
Assessment and management of behavioral and psychological symptoms of dementia. BMJ (2015) 1.27
Assessment and treatment of pain in people with dementia. Nat Rev Neurol (2012) 1.22
Pain management in patients with dementia. Clin Interv Aging (2013) 1.15
Efficacy of memantine for agitation in Alzheimer's dementia: a randomised double-blind placebo controlled trial. PLoS One (2012) 1.14
What should we know about dementia in the 21st century? A Delphi consensus study. BMC Geriatr (2015) 1.08
Pain and dementia: a diagnostic challenge. Z Gerontol Geriatr (2012) 0.96
The MOBID-2 pain scale: reliability and responsiveness to pain in patients with dementia. Eur J Pain (2014) 0.92
Medication development for agitation and aggression in Alzheimer disease: review and discussion of recent randomized clinical trial design. Int Psychogeriatr (2014) 0.91
Pain in people with Alzheimer disease: potential applications for psychophysical and neurophysiological research. J Geriatr Psychiatry Neurol (2012) 0.88
Tetrahydrocannabinol for neuropsychiatric symptoms in dementia: A randomized controlled trial. Neurology (2015) 0.87
Efficacy and tolerability of low-dose oral prolonged-release oxycodone/naloxone for chronic nononcological pain in older patients. Clin Interv Aging (2014) 0.87
Pain, agitation, and behavioural problems in people with dementia admitted to general hospital wards: a longitudinal cohort study. Pain (2015) 0.87
Association between pain, neuropsychiatric symptoms, and physical function in dementia: a systematic review and meta-analysis. BMC Geriatr (2015) 0.84
Pain is not the only cause of distress in dementia. BMJ (2011) 0.83
Nootropic activity of acetaminophen against colchicine induced cognitive impairment in rats. J Clin Biochem Nutr (2012) 0.82
Multi-psychotropic drug prescription and the association to neuropsychiatric symptoms in three Norwegian nursing home cohorts between 2004 and 2011. BMC Geriatr (2016) 0.81
Pain treatment for nursing home residents differs according to cognitive state - a cross-sectional study. BMC Geriatr (2016) 0.81
Comprehensive treatment of dementia with Lewy bodies. Alzheimers Res Ther (2015) 0.80
Identifying and Managing Pain in People with Alzheimer's Disease and Other Types of Dementia: A Systematic Review. CNS Drugs (2016) 0.79
Nurse-Led Medicines' Monitoring for Patients with Dementia in Care Homes: A Pragmatic Cohort Stepped Wedge Cluster Randomised Trial. PLoS One (2015) 0.79
COSMOS--improving the quality of life in nursing home patients: protocol for an effectiveness-implementation cluster randomized clinical hybrid trial. Implement Sci (2015) 0.79
Treating agitation in dementia. BMJ (2011) 0.79
Analgesic use, pain and daytime sedation in people with and without dementia in aged care facilities: a cross-sectional, multisite, epidemiological study protocol. BMJ Open (2014) 0.79
The brain signature of paracetamol in healthy volunteers: a double-blind randomized trial. Drug Des Devel Ther (2015) 0.79
Neuropsychiatric symptoms of dementia: consent, quality of life, and dignity. Biomed Res Int (2013) 0.79
Rehabilitation after hip fracture. Wien Med Wochenschr (2013) 0.78
Exploring the prevalence and variance of cognitive impairment, pain, neuropsychiatric symptoms and ADL dependency among persons living in nursing homes; a cross-sectional study. BMC Geriatr (2016) 0.78
The Interactive Relationship between Pain, Psychosis, and Agitation in People with Dementia: Results from a Cluster-Randomised Clinical Trial. Behav Neurol (2016) 0.78
Silent and suffering: a pilot study exploring gaps between theory and practice in pain management for people with severe dementia in residential aged care facilities. Clin Interv Aging (2014) 0.77
The role of the occupational therapist in the management of neuropsychiatric symptoms of dementia in clinical settings. Occup Ther Health Care (2014) 0.77
Behaviour management in dementia. Can Fam Physician (2011) 0.77
Dementia: Pain management in dementia--the value of proxy measures. Nat Rev Neurol (2014) 0.77
Measures to assess commonly experienced symptoms for people with dementia in long-term care settings: a systematic review. BMC Med (2016) 0.77
Decision Factors Nurses Use to Assess Pain in Nursing Home Residents With Dementia. Arch Psychiatr Nurs (2015) 0.76
Depressive symptoms are associated with analgesic use in people with Alzheimer's disease: Kuopio ALSOVA study. PLoS One (2015) 0.76
Drug use in patients with dementia: a register-based study in the health region of Girona (Catalonia/Spain). Eur J Clin Pharmacol (2012) 0.76
Factors Related to Rejection of Care and Behaviors Directed towards Others: A Longitudinal Study in Nursing Home Residents with Dementia. Dement Geriatr Cogn Dis Extra (2015) 0.76
Pain and psychological well-being among people with dementia in long-term care. Pain Med (2015) 0.76
ACP Journal Club. Systematic pain management reduced agitation in nursing home residents with dementia. Ann Intern Med (2011) 0.75
Increasing the Frequency and Timeliness of Pain Assessment and Management in Long-Term Care: Knowledge Transfer and Sustained Implementation. Pain Res Manag (2016) 0.75
Reduced thermal sensitivity and increased opioidergic tone in the TASTPM mouse model of Alzheimer's disease. Pain (2016) 0.75
Pharmacotherapy of neuropsychiatric symptoms of dementia. P T (2015) 0.75
Low back pain in older adults: risk factors, management options and future directions. Scoliosis Spinal Disord (2017) 0.75
Dementia: Pain relief--a first-line response to agitation in dementia? Nat Rev Neurol (2011) 0.75
Paracetamol sharpens reflection and spatial memory: a double-blind randomized controlled study in healthy volunteers. Drug Des Devel Ther (2016) 0.75
What is this thing called agitation? BMJ (2011) 0.75
Aromatherapy and Aromatic Plants for the Treatment of Behavioural and Psychological Symptoms of Dementia in Patients with Alzheimer's Disease: Clinical Evidence and Possible Mechanisms. Evid Based Complement Alternat Med (2017) 0.75
Analgesic use among nursing homes residents, with and without dementia, in Poland. Clin Interv Aging (2016) 0.75
Drug-based pain management for people with dementia after hip or pelvic fractures: a systematic review. BMC Geriatr (2017) 0.75
Low-dose oral prolonged-release oxycodone/naloxone for chronic pain in elderly patients with cognitive impairment: an efficacy-tolerability pilot study. Neuropsychiatr Dis Treat (2016) 0.75
Expert opinion on the management of pain in hospitalised older patients with cognitive impairment: a mixed methods analysis of a national survey. BMC Geriatr (2015) 0.75
[Quality assurance of pain care in Austria : Classification of management facilities]. Wien Med Wochenschr (2017) 0.75
Prevalence of and associations with agitation in residents with dementia living in care homes: MARQUE cross-sectional study. BJPsych Open (2017) 0.75
[Palliative care for patients with dementia]. Z Gerontol Geriatr (2012) 0.75
The Liverpool Care Pathway: a systematic review discarded in cancer patients but good enough for dying nursing home patients? BMC Med Ethics (2017) 0.75
Potentially inappropriate medication use in nursing homes: an observational study using the NORGEP-NH criteria. BMC Geriatr (2017) 0.75
"Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res (1975) 301.74
The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology (1994) 21.65
CONSORT statement: extension to cluster randomised trials. BMJ (2004) 16.50
Statistics notes: Analysing controlled trials with baseline and follow up measurements. BMJ (2001) 8.98
The Hawthorne Effect: a randomised, controlled trial. BMC Med Res Methodol (2007) 6.38
Position statement of the American Association for Geriatric Psychiatry regarding principles of care for patients with dementia resulting from Alzheimer disease. Am J Geriatr Psychiatry (2006) 3.22
Systematic review of psychological approaches to the management of neuropsychiatric symptoms of dementia. Am J Psychiatry (2005) 2.61
A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia. Neurology (1999) 2.51
A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia. J Clin Psychiatry (2003) 2.50
The management of chronic pain in older persons: AGS Panel on Chronic Pain in Older Persons. American Geriatrics Society. J Am Geriatr Soc (1998) 2.14
Repeatability and validity of a modified activities of daily living (ADL) index in studies of chronic disability. Int Rehabil Med (1979) 2.14
The prevalence of psychiatric symptoms and behavioural disturbances and the use of psychotropic drugs in Norwegian nursing homes. Int J Geriatr Psychiatry (2007) 1.91
Comparison of olanzapine and risperidone in the treatment of psychosis and associated behavioral disturbances in patients with dementia. Am J Geriatr Psychiatry (2005) 1.66
Nonpharmacological treatment of agitation: a controlled trial of systematic individualized intervention. J Gerontol A Biol Sci Med Sci (2007) 1.60
Effects of the Serial Trial Intervention on discomfort and behavior of nursing home residents with dementia. Am J Alzheimers Dis Other Demen (2006) 1.39
Who suffers most? Dementia and pain in nursing home patients: a cross-sectional study. J Am Med Dir Assoc (2008) 1.20
Effect of acetaminophen on behavior, well-being, and psychotropic medication use in nursing home residents with moderate-to-severe dementia. J Am Geriatr Soc (2005) 1.19
Prevalence and correlates of disruptive behavior in patients in Norwegian nursing homes. Int J Geriatr Psychiatry (2007) 1.18
Predictors of high level of burden and distress in caregivers of demented patients: results of an Italian multicenter study. Int J Geriatr Psychiatry (2005) 1.15
Brief psychosocial therapy for the treatment of agitation in Alzheimer disease (the CALM-AD trial). Am J Geriatr Psychiatry (2009) 1.14
Pain in older persons with severe dementia. Psychometric properties of the Mobilization-Observation-Behaviour-Intensity-Dementia (MOBID-2) Pain Scale in a clinical setting. Scand J Caring Sci (2010) 1.11
Assessment of agitation in elderly patients with dementia: correlations between informant rating and direct observation. Int J Geriatr Psychiatry (2004) 1.10
Pain treatment of agitation in patients with dementia: a systematic review. Int J Geriatr Psychiatry (2011) 1.09
Opioid treatment for agitation in patients with advanced dementia. Int J Geriatr Psychiatry (2003) 1.09
Verbal and physical non-aggressive agitated behaviors in elderly persons with dementia: robustness of syndromes. J Psychiatr Res (2005) 1.05
The utility of pain assessment for analgesic use in persons with dementia. Pain (2007) 1.02
Alzheimer's disease: a global challenge for the 21st century. Lancet Neurol (2009) 0.99
The Mahoney Pain Scale: examining pain and agitation in advanced dementia. Am J Alzheimers Dis Other Demen (2008) 0.89
CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. JAMA (2009) 7.29
Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord (2007) 6.92
Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial. Lancet (2011) 6.09
Donepezil and memantine for moderate-to-severe Alzheimer's disease. N Engl J Med (2012) 5.64
Alzheimer's disease. Lancet (2011) 5.35
Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines. Mov Disord (2012) 5.12
Rivastigmine for dementia associated with Parkinson's disease. N Engl J Med (2004) 4.56
Vascular cognitive impairment. Lancet Neurol (2003) 3.73
Effect of enhanced psychosocial care on antipsychotic use in nursing home residents with severe dementia: cluster randomised trial. BMJ (2006) 3.69
Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force. Mov Disord (2007) 3.48
Neuropathology of dementia in Parkinson's disease: a prospective, community-based study. Ann Neurol (2005) 3.31
Subtypes of mild cognitive impairment in Parkinson's disease: progression to dementia. Mov Disord (2006) 2.96
A systematic review of prevalence studies of depression in Parkinson's disease. Mov Disord (2008) 2.81
Dementia with Lewy bodies. Lancet Neurol (2004) 2.66
Changes in motor subtype and risk for incident dementia in Parkinson's disease. Mov Disord (2006) 2.47
Gray matter atrophy in Parkinson disease with dementia and dementia with Lewy bodies. Neurology (2007) 2.32
Conversion between mini-mental state examination, montreal cognitive assessment, and dementia rating scale-2 scores in Parkinson's disease. Mov Disord (2014) 2.30
MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI. Mov Disord (2011) 2.27
A multinational, randomised, 12-week study comparing the effects of donepezil and galantamine in patients with mild to moderate Alzheimer's disease. Int J Geriatr Psychiatry (2004) 2.21
Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial. Lancet Neurol (2009) 2.10
Effects of rivastigmine in patients with and without visual hallucinations in dementia associated with Parkinson's disease. Mov Disord (2006) 2.04
Identifying prodromal Parkinson's disease: pre-motor disorders in Parkinson's disease. Mov Disord (2012) 1.99
Good outcome in every fourth resuscitation attempt is achievable--an Utstein template report from the Stavanger region. Resuscitation (2011) 1.89
Ischemic basis for deep white matter hyperintensities in major depression: a neuropathological study. Arch Gen Psychiatry (2002) 1.88
Memantine for dementia in adults older than 40 years with Down's syndrome (MEADOWS): a randomised, double-blind, placebo-controlled trial. Lancet (2012) 1.88
Cognitive impairment in patients with Parkinson's disease: diagnosis, biomarkers, and treatment. Lancet Neurol (2012) 1.86
Sensory stimulation in dementia. BMJ (2002) 1.71
Scales to assess psychosis in Parkinson's disease: Critique and recommendations. Mov Disord (2008) 1.71
A 12-year population-based study of psychosis in Parkinson disease. Arch Neurol (2010) 1.70
Cerebrospinal fluid amyloid-β and phenotypic heterogeneity in de novo Parkinson's disease. J Neurol Neurosurg Psychiatry (2012) 1.66
Improving quality of life for people with dementia in care homes: making psychosocial interventions work. Br J Psychiatry (2012) 1.65
Diagnostic criteria for psychosis in Parkinson's disease: report of an NINDS, NIMH work group. Mov Disord (2007) 1.55
CSF amyloid-beta and tau proteins, and cognitive performance, in early and untreated Parkinson's disease: the Norwegian ParkWest study. J Neurol Neurosurg Psychiatry (2010) 1.55
Parkinson disease with dementia: comparing patients with and without Alzheimer pathology. Alzheimer Dis Assoc Disord (2009) 1.54
Use of drugs with anticholinergic effect and impact on cognition in Parkinson's disease: a cohort study. J Neurol Neurosurg Psychiatry (2009) 1.54
Progression of motor impairment and disability in Parkinson disease: a population-based study. Neurology (2005) 1.53
Neuropsychiatric symptoms in Alzheimer's disease: past progress and anticipation of the future. Alzheimers Dement (2013) 1.51
Neuropsychological profile of patients with Parkinson's disease without dementia. Dement Geriatr Cogn Disord (2003) 1.51
CSF amyloid β38 as a novel diagnostic marker for dementia with Lewy bodies. J Neurol Neurosurg Psychiatry (2010) 1.50
Validation of the Unified Parkinson's Disease Rating Scale (UPDRS) section I as a screening and diagnostic instrument for apathy in patients with Parkinson's disease. Parkinsonism Relat Disord (2007) 1.48
Stopping antipsychotic drug therapy in demented nursing home patients: a randomized, placebo-controlled study--the Bergen District Nursing Home Study (BEDNURS). Int J Geriatr Psychiatry (2008) 1.47
Drug repositioning for Alzheimer's disease. Nat Rev Drug Discov (2012) 1.42
Anti-psychotic drug use in older people. Age Ageing (2002) 1.39
A magnetic resonance imaging study of patients with Parkinson's disease with mild cognitive impairment and dementia using voxel-based morphometry. J Neurol Neurosurg Psychiatry (2006) 1.39
Management of behavioral problems in Alzheimer's disease. Int Psychogeriatr (2010) 1.38
Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies. Arch Neurol (2004) 1.33
Dopamine-induced proliferation of adult neural precursor cells in the mammalian subventricular zone is mediated through EGF. Proc Natl Acad Sci U S A (2009) 1.32
Hippocampal, caudate, and ventricular changes in Parkinson's disease with and without dementia. Mov Disord (2010) 1.31
Clinical practice with anti-dementia drugs: a consensus statement from British Association for Psychopharmacology. J Psychopharmacol (2006) 1.29
Hypertension is a potential risk factor for vascular dementia: systematic review. Int J Geriatr Psychiatry (2010) 1.28
White matter hyperintensities are associated with impairment of memory, attention, and global cognitive performance in older stroke patients. Stroke (2004) 1.26
Determining the minimum clinically important differences for outcomes in the DOMINO trial. Int J Geriatr Psychiatry (2010) 1.26
Parkinson's disease dementia and dementia with Lewy bodies: different aspects of one entity. Int Psychogeriatr (2009) 1.26
Salvia for dementia therapy: review of pharmacological activity and pilot tolerability clinical trial. Pharmacol Biochem Behav (2003) 1.25
The effect of staff training on agitation and use of restraint in nursing home residents with dementia: a single-blind, randomized controlled trial. J Clin Psychiatry (2010) 1.25
Frequency and case identification of dementia with Lewy bodies using the revised consensus criteria. Dement Geriatr Cogn Disord (2008) 1.24
Assessment and treatment of pain in people with dementia. Nat Rev Neurol (2012) 1.22
Verbal memory in drug-naive, newly diagnosed Parkinson's disease. The retrieval deficit hypothesis revisited. Neuropsychology (2011) 1.22
Optimised anaesthesia to reduce post operative cognitive decline (POCD) in older patients undergoing elective surgery, a randomised controlled trial. PLoS One (2012) 1.21
Is there an increase of postpartum hemorrhage, and is severe hemorrhage associated with more frequent use of obstetric interventions? Acta Obstet Gynecol Scand (2010) 1.21
Who suffers most? Dementia and pain in nursing home patients: a cross-sectional study. J Am Med Dir Assoc (2008) 1.20
Cognitive predictors of dementia in Parkinson's disease: a community-based, 4-year longitudinal study. J Geriatr Psychiatry Neurol (2005) 1.19
A comparison of (99m)Tc-HMPAO SPET changes in dementia with Lewy bodies and Alzheimer's disease using statistical parametric mapping. Eur J Nucl Med Mol Imaging (2002) 1.19
Caregiver burden in multiple sclerosis: the impact of neuropsychiatric symptoms. J Neurol Neurosurg Psychiatry (2007) 1.17
Depression in dementia: epidemiology, mechanisms, and treatment. Curr Opin Psychiatry (2011) 1.17
Caregiver preference for rivastigmine patches versus capsules for the treatment of Alzheimer disease. Neurology (2007) 1.16
The psychosocial burden on spouses of the elderly with stroke, dementia and Parkinson's disease. Int J Geriatr Psychiatry (2002) 1.15
Efficacy of memantine for agitation in Alzheimer's dementia: a randomised double-blind placebo controlled trial. PLoS One (2012) 1.14
The pattern of cognitive performance in CADASIL: a monogenic condition leading to subcortical ischemic vascular dementia. Am J Psychiatry (2005) 1.13
Autonomic function is impaired in elderly stroke survivors. Stroke (2005) 1.13
Medial temporal atrophy rather than white matter hyperintensities predict cognitive decline in stroke survivors. Neurobiol Aging (2006) 1.11
Frequency and correlates of caregiver-reported sleep disturbances in a sample of persons with early dementia. J Am Geriatr Soc (2010) 1.09
Depressive symptom profile in Parkinson's disease: a comparison with depression in elderly patients without Parkinson's disease. Int J Geriatr Psychiatry (2006) 1.08
Prevalence and clinical correlates of apathy in Parkinson's disease: a community-based study. Parkinsonism Relat Disord (2008) 1.08
Quality of chest compressions during 10min of single-rescuer basic life support with different compression: ventilation ratios in a manikin model. Resuscitation (2008) 1.08
Time until nursing home admission in people with mild dementia: comparison of dementia with Lewy bodies and Alzheimer's dementia. Int J Geriatr Psychiatry (2013) 1.07
Selective nicotinic acetylcholine receptor subunit deficits identified in Alzheimer's disease, Parkinson's disease and dementia with Lewy bodies by immunoprecipitation. Neurobiol Dis (2006) 1.06
Cognitive profiles of individual patients with Parkinson's disease and dementia: comparison with dementia with lewy bodies and Alzheimer's disease. Mov Disord (2006) 1.06
Gender-related differences in the burden of non-motor symptoms in Parkinson's disease. J Neurol (2012) 1.05
A novel blood test for the early detection of Alzheimer's disease. J Alzheimers Dis (2011) 1.04
Altered neurogenesis in Alzheimer's disease. J Psychosom Res (2006) 1.03
Executive dysfunction in mild cognitive impairment is associated with changes in frontal and cingulate white matter tracts. J Alzheimers Dis (2011) 1.02
Diffusion tensor imaging surpasses cerebrospinal fluid as predictor of cognitive decline and medial temporal lobe atrophy in subjective cognitive impairment and mild cognitive impairment. J Alzheimers Dis (2013) 1.01
Gray matter correlations of cognition in incident Parkinson's disease. Mov Disord (2010) 1.01
Pentagon drawing and neuropsychological performance in Dementia with Lewy Bodies, Alzheimer's disease, Parkinson's disease and Parkinson's disease with dementia. Int J Geriatr Psychiatry (2004) 1.01
Cognitive impairment in nondemented Parkinson's disease. Mov Disord (2011) 1.01
The disconnect between evidence and practice: a systematic review of person-centred interventions and training manuals for care home staff working with people with dementia. Int J Geriatr Psychiatry (2014) 0.99
Visual rating of white matter hyperintensities in Parkinson's disease. Mov Disord (2006) 0.98
Atypical antipsychotics for the treatment of behavioral and psychological symptoms in dementia, with a particular focus on longer term outcomes and mortality. Expert Opin Drug Saf (2010) 0.98
Is physical activity a potential preventive factor for vascular dementia? A systematic review. Aging Ment Health (2010) 0.98